XTL Biopharmaceuticals Ltd. (XTLB) Financials

$1.20

$0.02 (-1.64%)
Last update: 04:00 PM EST
Day's range
$1.14
Day's range
$1.28
$3M$3M$2M$2M$1M$1M$0$0-$1M-$1M-$2M-$2MEarning20182018201920192020202020212021202220222023202320242024-226.5%-226.5%-227%-227%-227.5%-227.5%-228%-228%-228.5%-228.5%-229%-229%Profit Margin
Profit Margin
Revenue
Earnings

XTLB Income statement / Annual

Last year (2024), XTL Biopharmaceuticals Ltd.'s total revenue was $451.00 K, and the percentage change from the previous year is not available. In 2024, XTL Biopharmaceuticals Ltd.'s net income was -$1.03 M. See XTL Biopharmaceuticals Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $451.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $448.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $3.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.01 0 0 0 0 0 0 0 0 0
Research and Development Expenses $98.00 K $31.00 K $30.00 K $30.00 K $38.00 K $35.00 K $38.00 K $43.00 K $443.00 K $578.00 K
General & Administrative Expenses $1.87 M $734.00 K $850.00 K $1.00 M $910.00 K $807.00 K $755.00 K $1.19 M $1.26 M $1.41 M
Selling & Marketing Expenses $178.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $2.05 M $734.00 K $850.00 K $1.00 M $910.00 K $807.00 K $755.00 K $1.19 M $1.26 M $1.41 M
Other Expenses $31.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $2.18 M $765.00 K $880.00 K $1.03 M $948.00 K $842.00 K $793.00 K $1.25 M $1.71 M $2.00 M
Cost And Expenses $2.62 M $765.00 K $880.00 K $1.03 M $948.00 K $842.00 K $793.00 K $1.25 M $1.71 M $2.00 M
Interest Income $34.00 K $36.00 $36.00 K $8.00 K $33.00 K $93.00 K $87.00 K $16.00 K $0.00 $0.00
Interest Expense $28.00 K $0.00 $0.00 $0.00 $0.00 $29.00 K $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $199.00 K $1.00 K $1.00 K $1.00 K $1.00 K $842.00 K $1.00 K $1.00 K $3.00 K $7.00 K
EBITDA -$930.00 K -$764.00 K -$879.00 K -$1.03 M -$947.00 K $0.00 -$792.00 K -$1.25 M -$1.71 M -$2.00 M
EBITDA Ratio -2.06 0 0 0 0 0 0 0 0 0
Operating Income Ratio -4.82 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $1.02 M -$1.02 M -$468.00 K $1.47 M -$2.01 M $79.00 K $4.42 M $465.00 K $16.00 K -$11.00 K
Income Before Tax -$1.16 M -$1.78 M -$1.35 M $435.00 K -$2.95 M -$1.35 M $2.99 M -$781.00 K -$2.55 M -$3.62 M
Income Before Tax Ratio -2.57 0 0 0 0 0 0 0 0 0
Income Tax Expense -$130.00 K $0.00 $468.00 K -$1.47 M $0.00 -$69.00 K -$80.00 K -$457.00 K $832.00 K $2.31 M
Net Income -$1.03 M -$1.78 K -$1.35 M $435.00 K -$782.00 K -$1.35 M $2.99 M -$781.00 K -$2.55 M -$4.31 M
Net Income Ratio -2.28 0 0 0 0 0 0 0 0 0
EPS -0.15 0 -0.25 0.1 -0.15 -0.26 0.58 -0.17 -0.93 -1.63
EPS Diluted -0.15 0 -0.25 0.07 -0.15 -0.26 0.58 -0.17 -0.93 -1.63
Weighted Average Shares Out $6.73 M $5.45 M $5.45 M $5.32 M $5.14 M $5.14 M $5.14 M $4.70 M $2.74 M $2.64 M
Weighted Average Shares Out Diluted $7.04 M $5.45 M $5.45 M $6.16 M $5.14 M $5.14 M $5.14 M $4.70 M $2.74 M $2.64 M
Link